hep3b (ATCC)
96
Structured Review
ATCC
hep3b
Hep3b, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1140 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hep+3b2%2E1-7/Hep+3B2%2E1-7/pm42285982-205-19-22
Average 96 stars, based on 1140 article reviews
Hep3b, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1140 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/hep+3b2%2E1-7/Hep+3B2%2E1-7/pm42285982-205-19-22
Average 96 stars, based on 1140 article reviews
hep3b - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
Modification:Article Title: The RNA helicase domain of NAT10 promotes the biogenesis of hypomodified ribosomes to enhance cancer cell proliferation Article Snippet: . All other experiments were conducted under protocol BIO20250026, approved by the Northwestern University Institutional Biosafety Committee (IBC). Hep3B (human hepatocellular carcinoma, Cat#:HB-8064, Cell Culture:Article Title: The RNA helicase domain of NAT10 promotes the biogenesis of hypomodified ribosomes to enhance cancer cell proliferation Article Snippet: . All other experiments were conducted under protocol BIO20250026, approved by the Northwestern University Institutional Biosafety Committee (IBC). Hep3B (human hepatocellular carcinoma, Cat#:HB-8064, Single Cell Gel Electrophoresis:Article Title: The RNA helicase domain of NAT10 promotes the biogenesis of hypomodified ribosomes to enhance cancer cell proliferation Article Snippet: . All other experiments were conducted under protocol BIO20250026, approved by the Northwestern University Institutional Biosafety Committee (IBC). Hep3B (human hepatocellular carcinoma, Cat#:HB-8064, Incubation:Article Title: The RNA helicase domain of NAT10 promotes the biogenesis of hypomodified ribosomes to enhance cancer cell proliferation Article Snippet: . All other experiments were conducted under protocol BIO20250026, approved by the Northwestern University Institutional Biosafety Committee (IBC). Hep3B (human hepatocellular carcinoma, Cat#:HB-8064, Isolation:Article Title: The RNA helicase domain of NAT10 promotes the biogenesis of hypomodified ribosomes to enhance cancer cell proliferation Article Snippet: . All other experiments were conducted under protocol BIO20250026, approved by the Northwestern University Institutional Biosafety Committee (IBC). Hep3B (human hepatocellular carcinoma, Cat#:HB-8064, Mouse Assay:Article Title: The RNA helicase domain of NAT10 promotes the biogenesis of hypomodified ribosomes to enhance cancer cell proliferation Article Snippet: . All other experiments were conducted under protocol BIO20250026, approved by the Northwestern University Institutional Biosafety Committee (IBC). Hep3B (human hepatocellular carcinoma, Cat#:HB-8064, Planar Chromatography:Article Title: The RNA helicase domain of NAT10 promotes the biogenesis of hypomodified ribosomes to enhance cancer cell proliferation Article Snippet: . All other experiments were conducted under protocol BIO20250026, approved by the Northwestern University Institutional Biosafety Committee (IBC). Hep3B (human hepatocellular carcinoma, Cat#:HB-8064, Recombinant:Article Title: The RNA helicase domain of NAT10 promotes the biogenesis of hypomodified ribosomes to enhance cancer cell proliferation Article Snippet: . All other experiments were conducted under protocol BIO20250026, approved by the Northwestern University Institutional Biosafety Committee (IBC). Hep3B (human hepatocellular carcinoma, Cat#:HB-8064, |